Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
ACG Case Reports Journal|July 28, 2023
Rapidly Progressive Portal Cavernoma Cholangiopathy in a Patient With Infeasible Decompressive Shunt SurgeryMaria Yu Nadinskaia, Vladimir T Ivashkin, Tatiana Р Nekrasova, et al.
Diabetes, Obesity & Metabolism|August 18, 2017
Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1cBaptist Gallwitz, Samuel Dagogo-Jack, Vivian Thieu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 12, 2013
Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitusChieh-Hsiang Lu, Ta-Jen Wu, Kuang-Chung Shih, et al.
Frontiers in Human Neuroscience|August 14, 2025
Neurophysiological evidence of single-shot semantic mapping in the developing brainMarina J Vasilyeva, Veronika M Knyazeva, Elena D Artemenko, et al.
Nanomaterials (Basel, Switzerland)|December 17, 2024
Menthol-Induced Chirality in Semiconductor Nanostructures: Chiroptical Properties of Atomically Thin 2D CdSe Nanoplatelets Capped with Enantiomeric L-(-)/D-(+)-Menthyl ThioglycolatesMaria Yu Skrypnik, Daria A Kurtina, Sofia P Karamysheva, et al.
Diagnostics (Basel, Switzerland)|January 16, 2020
The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate NeoplasmsMaria Yu Konoshenko, Evgeniy A Lekchnov, Olga E Bryzgunova, et al.
The Journal of Physical Chemistry. B|January 17, 2014
How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag-time of aggregation. II. Experimental application for insulin and LysPro insulin: aggregation morphology, kinetics, and sizes of nucleiOlga M Selivanova, Maria Yu Suvorina, Nikita V Dovidchenko, et al.
Diabetes, Obesity & Metabolism|September 13, 2023
The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomesFrancesco Giorgino, Bruno Guerci, Martin Füchtenbusch, et al.
Cell Systems|April 18, 2024
The resilience of Ukrainian scientistsOksana Piven, Valerii Pokrytiuk, Nadiia Kasianchuk, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2023
Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial ProgrammeKristina S Boye, Vivian Thuyanh Thieu, Hélène Sapin, et al.
Pageof 10